Prophylactic administration of clindamycin 2 % vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: A randomised placebo-controlled double-blind trial

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 106, Issue 7, 1999, Pages 652-657

  Vermeulen, Gustaaf M ^a   Bruinse, Hein W ^b  

^a Diaconessenhuis Meppel ^*  (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN;

ADULT; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HIGH RISK PATIENT; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INFECTION; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK;

ANTIBIOTICS; DEMOGRAPHIC FACTORS; DEVELOPED COUNTRIES; DOUBLE-BLIND STUDIES; DRUGS; EUROPE; NETHERLANDS; POPULATION; POPULATION CHARACTERISTICS; PREGNANCY; PREGNANCY OUTCOMES; PREGNANT WOMEN; PREMATURE BIRTH--PREVENTION AND CONTROL; REPRODUCTION; RESEARCH METHODOLOGY; RESEARCH REPORT; STUDIES; TREATMENT; WESTERN EUROPE;

ADULT; ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DOUBLE-BLIND METHOD; FEMALE; HUMANS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 0033044642     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1999.tb08363.x     Document Type: Article

References (23)

1. Hueston WJ, Knox MA, Eilers G. Pauwels J, Lonsdorf D. The effectiveness of preterm-birth prevention educational programs for highrisk women: A meta-analysis. Obstet Gynecol 1995; 86: 705–712.
2. Roberts WE, Morrison JC, Hamer C, Wiser WL. The incidence of preterm labor and specific risk factors. Obstet Gynecol 1990; 76: 85 S–89 S.
3. McGregor JA, French JI, Lawellin D, Todd JK. term birth and infection: Pathogenic possibilities. Am J Reprod Immun Microb 1988; 16: 123–132.
4. Riduan JM, Hillier SL, Utomo B, Wiknjosastro G, Linnan M, Kandun N. Bacterial vaginosis and prematurity in Indonesia: Association in early and late pregnancy. Am J Obstet Gynecol 1993; 169: 175–178.
5. Hay PE, Morgan DJ, Ison CA et al. A longitudinal study of bacterial vaginosis during pregnancy. Br J Obstet Gynaecol 1994; 101: 1048–1053.
6. Hillier SL, Nugent RP, Eschenbach DA et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 1995; 333: 1737–1742.
7. Spiegel CA. Bacterial vaginosis. Clin Microbiol Rev 1991; 4: 485–502.
8. Hillier SL, Krohn MA, Rabe LK, Klebanoff SJ, Eschenbach DA. The normal vaginal flora, H2 02-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin Infect Dis 1993; 16 (Suppl 4): S273–S281.
9. Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL. A review of premature birth and subclinical infection. Am J Obstet Gynecol 1992; 166: 1515–1528.
10. Greaves WL, Chungafung J, Moms B, Haile A, Townsend JL. Clindamycin vs metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol 1988; 72: 799–802.
11. Livengood CH III, Thomason JL, Hill GB. Bacterial vaginosis: Treatment with topical intravaginal clindamycin phosphate. Obstet Gynecol 1990; 76: 118–123.
12. Hillier SL, Krohn MA, Watts DH, Wolner-Hanssen P, Eschenbach D. Microbiologic efficacy of intravaginal clindamycin cream for the treatment of bacterial vaginosis. Obstet Gynecol 1990; 76: 407–413.
13. Carr-Hill RA, Hall MH. The repetition of spontaneous preterm labor. Br J Obstet Gynaecol 1985; 92: 921–928.
14. Keirse MJNC, Rush RW, Anderson ABM, Turnbull AC. Risk of preterm delivery in patients with previous pre–term delivery and/or abortion. Br J Obstet Gynaecol 1978; 85: 81–85.
15. Harger JH, Hsing AW, Tuomala RE et al. Risk factors for preterm premature rupture of fetal membranes: A multicenter case-control study. Am J Obstet Gynecol 1990; 163: 130–137.
16. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 22: 297–301.
17. Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995; 333: 1732–1736.
18. McDonald HM, O’Loughlin JA, Vigneswaran R et al. Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): A randomised, placebo controlled trial. Br J Obstet Gynaecol 1997; 104: 1391–1397.
19. Hill GB, Livengood CH 3rd. Bacterial vaginosis-associated microflora and effects of topical intravaginal clindamycin. Am J Obster Gynecol 1994; 171: 1198–1204.
20. Zambrano D. Clindamycin in the treatment of obstetric and gynecologic infections: A review. Clin Ther 1991; 13: 58–80.
21. Morales WJ, Schorr S, Albritton J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: A placebo-controlled, double-blind study. Am J Obstet Gynecol 1994; 171: 345–349.
22. McGregor JA, French JI, Jones W et al. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol 1994 170: 1048–1060.
23. Joesoef MR, Hillier SL, Wiknjosastro G et al. Intravaginal clindamycin treatment for bacterial vaginosis: Effects on preterm delivery and low birth weight. Am J Obstet Gynecol 1995; 173: 1527–1531.